CECO Earnings

CECO reported its earnings on 2026-02-27, showcasing a revenue of 0.00 against an estimate of 209.00M, resulting in a 0% surprise. The EPS was 0, surpassing the expected 0.43 by 0% . The stock experienced a 0% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following CECO's earnings announcement on 2026-02-27, the stock price moved by % on the day of the release. Over the subsequent five days, it saw a % change. Historically, CECO's stock price tends to shift by an average of +0.33% in the 10 days leading up to earnings and +9.88% in the 10 days following, providing insight into potential market.

For 2025/Q4, analysts estimate CECO’s annual revenue to reach 205.00M, while the EPS is projected at 0.00. These estimates reflect recent revisions, with revenue estimates revised Revenue Revise Upward by 0.55% and EPS estimates Revise Upward by 0.31% over the past three months, indicating analyst expectation in the company’s performance.

The correlation between CECO's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were Revise Upward by 0.55%, while EPS estimates moved Revise Upward by 0.31% . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, CECO's stock price typically moves by +0.33% in the 10 days before its earnings and +9.88% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of 0.00 and revenue of 205.00M.

The overall sentiment is positive with raised guidance for 2025 orders and revenue, robust market demand, and a strong pipeline. The Q&A section highlights confidence in future growth, despite some macroeconomic uncertainties and capacity constraints. The company is also exploring M&A opportunities and expanding cross-selling efforts. While there are minor concerns about margin declines and unclear responses, the positive outlook for revenue, EBITDA, and shareholder returns outweighs these.